Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$58.41 - $90.35 $954,945 - $1.48 Million
16,349 New
16,349 $1.17 Million
Q3 2022

Nov 09, 2022

BUY
$36.06 - $69.85 $165,948 - $321,449
4,602 New
4,602 $205,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.56B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.